These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

226 related items for PubMed ID: 17671066

  • 1. Efficacy of zolmitriptan nasal spray in adolescent migraine.
    Lewis DW, Winner P, Hershey AD, Wasiewski WW, Adolescent Migraine Steering Committee.
    Pediatrics; 2007 Aug; 120(2):390-6. PubMed ID: 17671066
    [Abstract] [Full Text] [Related]

  • 2. Speed of onset and efficacy of zolmitriptan nasal spray in the acute treatment of migraine: a randomised, double-blind, placebo-controlled, dose-ranging study versus zolmitriptan tablet.
    Charlesworth BR, Dowson AJ, Purdy A, Becker WJ, Boes-Hansen S, Färkkilä M.
    CNS Drugs; 2003 Aug; 17(9):653-67. PubMed ID: 12828501
    [Abstract] [Full Text] [Related]

  • 3. Speed of onset, efficacy and tolerability of zolmitriptan nasal spray in the acute treatment of migraine: a randomised, double-blind, placebo-controlled study.
    Dodick D, Brandes J, Elkind A, Mathew N, Rodichok L.
    CNS Drugs; 2005 Aug; 19(2):125-36. PubMed ID: 15697326
    [Abstract] [Full Text] [Related]

  • 4. Zolmitriptan 5 mg nasal spray: efficacy and onset of action in the acute treatment of migraine--results from phase 1 of the REALIZE Study.
    Gawel M, Aschoff J, May A, Charlesworth BR, REALIZE Study Team.
    Headache; 2005 Jan; 45(1):7-16. PubMed ID: 15663607
    [Abstract] [Full Text] [Related]

  • 5. Efficacy and tolerability of zolmitriptan nasal spray for the treatment of acute migraine in adolescents: Results of a randomized, double-blind, multi-center, parallel-group study (TEENZ).
    Winner P, Farkas V, Štillová H, Woodruff B, Liss C, Lillieborg S, Raines S, TEENZ Study Group.
    Headache; 2016 Jul; 56(7):1107-19. PubMed ID: 27329280
    [Abstract] [Full Text] [Related]

  • 6. Tolerability and consistency of effect of zolmitriptan nasal spray in a long-term migraine treatment trial.
    Dowson AJ, Charlesworth BR, Purdy A, Becker WJ, Boes-Hansen S, Färkkilä M.
    CNS Drugs; 2003 Jul; 17(11):839-51. PubMed ID: 12921494
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Zolmitriptan for acute migraine attacks in adults.
    Bird S, Derry S, Moore RA.
    Cochrane Database Syst Rev; 2014 May 21; 2014(5):CD008616. PubMed ID: 24848613
    [Abstract] [Full Text] [Related]

  • 15. Effectiveness of intranasal zolmitriptan in acute cluster headache: a randomized, placebo-controlled, double-blind crossover study.
    Cittadini E, May A, Straube A, Evers S, Bussone G, Goadsby PJ.
    Arch Neurol; 2006 Nov 21; 63(11):1537-42. PubMed ID: 16966497
    [Abstract] [Full Text] [Related]

  • 16. Efficacy of ADAM Zolmitriptan for the Acute Treatment of Difficult-to-Treat Migraine Headaches.
    Tepper SJ, Dodick DW, Schmidt PC, Kellerman DJ.
    Headache; 2019 Apr 21; 59(4):509-517. PubMed ID: 30698272
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.